Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LidoDyn for venipuncture pain in children
NCT00562211Phase 2Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Nov 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of LidoDyn in pain, sponsored by Rambam Health Care Campus. Primary endpoint: Visual Analog Scale Pain. Started Nov 2007; status: completed.
02
Drugs
LidoDyn
03
Conditions
pain
Beyond the preview
Go deeper on NCT00562211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00562211.